Eric Hou Hu

US Patent:

20220324866, Oct 13, 2022

Filed:

Dec 18, 2020

Appl. No.:

17/127297

Inventors:

- Foster City CA, US
- Kobe-shi, JP
Ryoko NAKAI - Kobe-shi, JP
Hirokazu MATSUMOTO - Kobe-shi, JP
Catherine PUGH - Foster City CA, US
Eric HU - Foster City CA, US
Juan GUERRERO - Foster City CA, US
Jesse JACOBSEN - Foster City CA, US
Jonathan William MEDLEY - Foster City CA, US
Jie XU - Foster City CA, US
Latesh LAD - Foster City CA, US
Leena PATEL - Foster City CA, US
Michael GRAUPE - Foster City CA, US
Qingming ZHU - Foster City CA, US
Stephen HOLMBO - Foster City CA, US
Tetsuya KOBAYASHI - Foster City CA, US
Will WATKINS - Foster City CA, US
Yasamin MOAZAMI - Foster City CA, US
Suet C. YEUNG - Foster City CA, US
Julian A. CODELLI - Foster City CA, US
Heath A. WEAVER - Foster City CA, US

International Classification:

C07D 487/04
C07D 519/00
A61K 31/519
A61K 31/538
A61K 31/55
A61K 31/395
A61K 31/695
C07F 7/18
A61K 31/5377
A61K 31/553
A61K 45/06
A61K 39/395
A61K 31/704
A61K 31/7068
A61K 35/17
A61K 35/15

Abstract:

The present disclosure provides diacylglycerol kinase modulating compounds, and pharmaceutical compositions thereof, for treating cancer, including solid tumors, and viral infections, such as HIV or hepatitis B virus infection. The compounds can be used alone or in combination with other agents.

US Patent:

20220204956, Jun 30, 2022

Filed:

Dec 20, 2021

Appl. No.:

17/556504

Inventors:

- Hayward CA, US
Xiyun Zhang - San Ramon CA, US
William Buchanan Porterfield - Oakland CA, US
Wenhua Lu - Dublin CA, US
Khin Oo - Daly City CA, US
Goutami Banerjee - Daly City CA, US
Tatsuya Fukushima - Fremont CA, US
Eric Lin Hu - Millbrae CA, US

Assignee:

Fornia BioSolutions, Inc. - Hayward CA

International Classification:

C12N 9/42
C12N 15/63

Abstract:

The invention is directed to novel variant endoglucanases and their use thereof.

US Patent:

20230108132, Apr 6, 2023

Filed:

Jul 22, 2022

Appl. No.:

17/814417

Inventors:

- Hayward CA, US
Jie YANG - Foster City CA, US
Goutami BANERJEE - Hayward CA, US
Khin OO - Daly City CA, US
Marielle De Jesus PALATINO - Stockton CA, US
Eric Lin HU - Millbrae CA, US
Imad N. SAWAYA - Redwood City CA, US
Tatsuya FUKUSHIMA - Fremont CA, US
Jijiao ZENG - Albany CA, US
Wenhua LU - Dublin CA, US

Assignee:

Fornia BioSolutions, Inc. - Hayward CA

International Classification:

C12N 9/34
C12N 1/14
C12N 1/16
C12N 1/20
C12N 15/52
C12N 15/74
C12N 15/80
C12N 15/81
C12P 19/14
C12N 15/70

Abstract:

The invention is directed to novel variant glucoamylases.

US Patent:

20200299656, Sep 24, 2020

Filed:

Sep 10, 2019

Appl. No.:

16/566494

Inventors:

- Hayward CA, US
Jie Yang - Foster City CA, US
Xiyun Zhang - San Ramon CA, US
Goutami Banerjee - Hayward CA, US
Tatsuya Fukushima - Fremont CA, US
Eric Lin Hu - Millbrae CA, US
Imad N. Sawaya - Redwood City CA, US
Stephen Joshua Macaso Millet - Tracy CA, US
Jijiao Zeng - Albany CA, US
Wenhua Lu - Dublin CA, US

International Classification:

C12N 9/16
C12N 15/81
A23K 20/189

Abstract:

The present invention relates to variant phytase enzymes and their use thereof.

US Patent:

20200231955, Jul 23, 2020

Filed:

Jan 15, 2020

Appl. No.:

16/744016

Inventors:

- Hayward CA, US
Khin Oo - Daly City CA, US
Goutami Banerjee - Hayward CA, US
Xiyun Zhang - San Ramon CA, US
Wenhua Lu - Dublin CA, US
Stephen Joshua Macaso Millet - Tracy CA, US
Tatsuya Fukushima - Fremont CA, US
Eric Lin Hu - Millbrae CA, US
Imad N. Sawaya - Redwood City CA, US
Marielle De Jesus Palatino - Stockton CA, US

International Classification:

C12N 9/42

Abstract:

The invention is directed to novel variant endoglucanases.

US Patent:

20200199560, Jun 25, 2020

Filed:

Nov 12, 2019

Appl. No.:

16/681678

Inventors:

- Hayward CA, US
Jie YANG - Foster City CA, US
Goutami BANERJEE - Hayward CA, US
Khin OO - Daly City CA, US
Marielle De Jesus PALATINO - Stockton CA, US
Eric Lin HU - Millbrae CA, US
Imad N. SAWAYA - Redwood City CA, US
Tatsuya FUKUSHIMA - Fremont CA, US
Jijiao ZENG - Albany CA, US
Wenhua LU - Dublin CA, US

International Classification:

C12N 9/34

Abstract:

The invention is directed to novel variant glucoamylases.

US Patent:

20190338264, Nov 7, 2019

Filed:

May 2, 2019

Appl. No.:

16/402172

Inventors:

- Hayward CA, US
Jie Yang - Foster City CA, US
Khin Oo - Daly City CA, US
Goutami Banerjee - Hayward CA, US
Tatsuya Fukushima - Fremont CA, US
Eric Lin Hu - Millbrae CA, US
Marielle De Jesus Palatino - Stockton CA, US
Jijiao Zeng - Albany CA, US
Imad N. Sawaya - Redwood City CA, US

International Classification:

C12N 9/24
C12P 19/14
C11D 3/386
C12P 7/06
A21D 8/04

Abstract:

The invention is directed to novel amylases.

US Patent:

20150223804, Aug 13, 2015

Filed:

Feb 6, 2015

Appl. No.:

14/615786

Inventors:

- Los Altos CA, US
Eric Y. Hu - Los Altos CA, US
Po-Hua Lee - Los Altos CA, US
Hsiao-Wei Tang - Taipei, TW
Shuling Cheng - Taipei, TW

International Classification:

A61B 17/04

Abstract:

Systems are provided for delivering a suture to close a surgical opening. An elongated deployment member may have at its distal end a retracted counterforce member. The counterforce member may be inserted into the surgical opening and deployed to resist being withdrawn from the opening. A compression member may be slid down the elongated member to compress the tissue to be sutured against the counterforce member. Suture passers loaded with suture ends may be passed through needle tubes within the elongated member to emerge from the elongated member and pierce the tissue to be sutured, then deposit the suture ends with a suture catcher. The suture passers may be withdrawn, leaving the suture ends. The suture catcher may be retracted, retaining the suture ends and the device—elongated member, retracted suture catcher, and retained suture end—may be withdrawn from the surgical opening. The suture may then be completed.